Legend Biotech Corporation (NASDAQ:LEGN) Q3 2023 Earnings Call Transcript

Operator: Good day, ladies and gentlemen. Thank you for standing by. Welcome to Legend Biotech Reports Third Quarter 2023 Financial Results Conference Call.

Related Keywords

China ,Belgium ,Switzerland ,India ,Germany ,Netherlands ,Kelly Shi ,Ying Huang ,Guowei Fang ,Jessie Yeung ,Gena Wang ,Jessica Fye ,Bristol Beckman ,Lori Macomber ,Head Of Commercial Development ,Health Products ,Novartis Pharmaceuticals Corporation ,Global Development Plan ,Clinical Service Agreement ,Agency For Medicines ,Novartis ,Master Technology ,Barclays ,Legend Biotech Corporation ,Call Transcript November ,Biotech Corporation ,Legend Biotech Reports Third Quarter ,Results Conference ,Investor Relations ,Public Relations ,Chief Executive Officer ,Chief Financial ,Chief Scientific Officer ,Steve Gavel ,Commercial Development ,Federal Agency ,Investigational Medicinal Product Dossier ,Janssen Agreement ,Master Technology Transfer ,Novartis Pharmaceuticals ,Legend Biotech ,Profitable Businesses With Least Investment ,Hey Kelly ,